市場調查報告書
商品編碼
1530698
2030 年替代蛋白質市場預測:按原產地、形式、生產流程、分銷管道、應用和地區進行的全球分析Protein Alternatives Market Forecasts to 2030 - Global Analysis By Source, Form, Production Process, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,2024 年全球替代蛋白市場規模為 275.5 億美元,預計到 2030 年將達到 759.1 億美元,預測期內複合年成長率為 18.4%。
替代蛋白質是替代或補充傳統動物蛋白質的非傳統蛋白質來源。這些替代蛋白質通常源自於植物、真菌或培養動物組織,為尋求永續、道德或健康相關飲食的個人提供了多種選擇。大豆、扁豆和藜麥等植物蛋白因其完整的氨基酸譜和高營養價值而成為著名的例子。
根據聯合國糧食及農業組織預測,到2050年,食品和飼料用穀物的需求量預計將從目前的近21億噸增加到30億噸左右。
素食者和素食主義者的數量不斷增加
素食者和素食人口的成長正在推動對替代蛋白質和創新的需求,重塑食品產業格局。隨著越來越多的人出於健康、環境和道德原因採用植物性飲食,對傳統動物食品以外的蛋白質來源的需求正在增加。這種轉變推動了大豆、豌豆、鷹嘴豆和大麻等植物性蛋白質的激增。替代蛋白的興起不僅滿足了純素食者和素食者的偏好,也吸引了廣大尋求更健康、更永續食品的人。
監管障礙
替代蛋白質市場面臨重大挑戰,監管障礙成為創新和市場進入的障礙。世界各地有關食品安全、標籤和成分核准的法規各不相同,這使得替代蛋白質產品的開發和分銷變得複雜。在某些地區,對新原料和製造方法的嚴格要求可能會延遲產品上市並增加製造商的成本。 「植物來源的」、「實驗室種植的」和「培養的」等術語的不同定義和標準使監管合規性和消費者理解更加複雜。
對替代蛋白質的需求不斷成長
對替代蛋白質不斷成長的需求代表著全球食品產業的變革。這一趨勢是由多種因素驅動的,包括環境問題、健康考量和道德動機。替代蛋白質包括多種來源,包括植物蛋白質(如大豆、豌豆和扁豆)、培養蛋白質(透過細胞農業生產)和新來源(如藻類和昆蟲)。此外,越來越多的消費者選擇這些替代蛋白,因為永續性、對環境影響低,且營養價值可與傳統動物蛋白相媲美。
微生物風險和過敏反應
微生物風險來自於生產這些替代食品的製造過程,例如發酵和培養方法,如果不嚴格控制,可能會導致污染。消費者對食品安全和品質標準的期望加劇了這種擔憂。過敏反應也是一個重大障礙,因為對常見植物性蛋白質(大豆、堅果等)和替代蛋白產品中使用的其他成分過敏的人可能會出現副作用。這些問題會影響消費者信心和監管,從而阻礙市場成長,導致產業參與者大力投資研發和採取嚴格的品管措施來減輕這些風險。
COVID-19 大流行對替代蛋白質市場產生了重大影響。隨著危機的展開,供應鏈和製造中斷對肉類等傳統蛋白質來源的生產和分銷帶來了挑戰。這導致消費者對替代蛋白質來源的興趣和需求增加,例如植物性蛋白質,它們對供應鏈中斷的抵抗力更強,並且具有健康和永續性。然而,這場大流行凸顯了人們對通用感染疾病的擔憂,並進一步增加了人們對植物蛋白和其他非傳統蛋白質來源作為更安全替代品的興趣。
藻類蛋白部分預計在預測期內成長最高
透過提供大豆和乳清等傳統蛋白質來源的永續營養豐富的替代品,預計藻類蛋白質領域在預測期內將成長最大。藻類,特別是螺旋藻和小球藻等微藻類,營養豐富,富含必需胺基酸、維生素和礦物質。種植藻類是環保且擴充性的,因為與傳統作物相比,它需要最少的土地和淡水。由於藻類蛋白不含大豆和乳製品中常見的過敏原,因此這項創新將吸引尋求植物性或素食飲食的消費者。
預計專賣店細分市場在預測期間的複合年成長率最高
透過提供針對注重健康的消費者的偏好客製化的多樣化和創新產品,預計專賣店領域在預測期內將實現最高的複合年成長率。這些商店專門滿足對植物蛋白不斷成長的需求,並提供豆腐、Tempeh、素肉和各種豆類產品等替代品。與傳統超級市場不同,專賣店通常為純素、素食者和彈性素食者提供精心挑選的高品質、小眾產品。此外,它也是教育和探索的中心,引入新的蛋白質來源和永續食品選擇,以促進環境責任。
由於人們對畜牧業相關健康和永續性議題的認知不斷增強,以及越來越多的消費者採用素食和彈性飲食,歐洲地區在估計期間佔據了最大的市場佔有率。植物性蛋白質提供了傳統動物性蛋白質的可行替代品,並適應各種飲食偏好和生活方式。此外,食品科技創新正在開發模仿肉類和乳製品的味道、質地和營養成分的植物性產品,進一步推動該地區的成長。
預計歐洲地區在預測期內將顯著成長。針對永續性、健康和動物福利的嚴格法規正在鼓勵食品製造商在全部區域創新並實現產品多樣化。促進植物性飲食、減少肉類消費和促進永續農業實踐的政策將在該全部區域因此,歐洲已成為替代蛋白質的中心,吸引投資並推動市場成長,同時促進向更永續和健康的食品選擇的轉變。
According to Stratistics MRC, the Global Protein Alternatives Market is accounted for $27.55 billion in 2024 and is expected to reach $75.91 billion by 2030 growing at a CAGR of 18.4% during the forecast period. Protein alternatives refer to non-traditional sources of protein that can substitute or complement conventional animal-based proteins. These alternatives are typically derived from plants, fungi, or even cultivated animal tissues, offering diverse options for individuals seeking sustainable, ethical, or health-related dietary choices. Plant-based proteins, such as soybeans, lentils, and quinoa, are prominent examples due to their complete amino acid profiles and high nutritional value.
According to the Food and Agriculture Organization, by 2050, the demand for cereals is expected to increase from its current level of close to 2.1 billion tons to around 3 billion tons for both food and animal feed.
Increasing vegan and vegetarian population
The increasing vegan and vegetarian population is driving the demand and innovation in protein alternatives, reshaping the food industry landscape. As more people adopt plant-based diets for health, environmental, and ethical reasons, there's a growing need for protein sources beyond traditional animal products. This shift has spurred a surge in plant-based protein options such as soy, pea, chickpea, and hemp, which are not only rich in protein but also offer diverse nutritional benefits. The rise in protein alternatives is not only meeting the dietary preferences of vegans and vegetarians but also appealing to a broader audience seeking healthier and sustainable food options.
Regulatory hurdles
The Protein Alternatives Market faces significant challenges due to regulatory hurdles, which pose barriers to innovation and market entry. Regulations governing food safety, labeling, and ingredient approval vary globally, complicating the development and distribution of alternative protein products. In some regions, stringent requirements for new ingredients or production methods can delay product launches and increase costs for manufacturers. Differing definitions and standards for terms like "plant-based," "lab-grown," or "cultivated" further complicate regulatory compliance and consumer understanding.
Rising demand for alternate protein
The rising demand for alternative proteins signifies a transformative shift in the global food industry. This trend is driven by several factors, including environmental concerns, health considerations, and ethical motivations. Alternative proteins encompass a diverse range of sources such as plant-based proteins (like soy, pea, and lentils), cultured proteins (produced through cellular agriculture), and novel sources (such as algae or insects). Furthermore, consumers are increasingly opting for these alternatives due to their perceived sustainability, lower environmental impact, and nutritional benefits comparable to traditional animal-based proteins.
Microbial risk and allergic reactions
Microbial risks arise from the production processes involved in creating these alternatives, such as fermentation or cultivation methods, which may lead to contamination if not rigorously controlled. This concern is amplified by consumer expectations for food safety and quality standards. Allergic reactions pose another significant hurdle, as individuals with allergies to common plant-based proteins (e.g., soy, nuts) or other ingredients used in alternative protein products may experience adverse effects. These issues hinder market growth by affecting consumer confidence and regulatory scrutiny, prompting industry players to invest heavily in research, development, and stringent quality control measures to mitigate these risks.
The COVID-19 pandemic significantly influenced the protein alternatives market. As the crisis unfolded, disruptions in supply chains and manufacturing posed challenges to the production and distribution of traditional protein sources such as meat. This led to increased consumer interest and demand for alternative protein options like plant-based proteins, which were perceived as more resilient to supply chain disruptions and were also associated with health and sustainability benefits. However, the pandemic highlighted concerns over zoonotic diseases, further driving interest in plant-based and other non-traditional protein sources as safer alternatives.
The Algae Protein segment is expected to be the largest during the forecast period
Algae Protein segment is expected to be the largest during the forecast period by offering a sustainable and nutritious alternative to traditional protein sources like soy and whey. Algae, particularly microalgae such as spirulina and chlorella, are rich in essential amino acids, vitamins, and minerals, making them highly nutritious. Algae cultivation requires minimal land and freshwater compared to traditional crops, making it environmentally friendly and scalable. This innovation appeals to consumers seeking plant-based or vegan diets, as algae proteins are free from allergens commonly found in soy and dairy products.
The Specialty Store segment is expected to have the highest CAGR during the forecast period
Specialty Store segment is expected to have the highest CAGR during the forecast period by offering a diverse range of innovative products tailored to the preferences of health-conscious consumers. These stores cater specifically to the growing demand for plant-based proteins, offering alternatives such as tofu, tempeh, seitan, and various legume-based products. Unlike conventional supermarkets, Specialty Stores often provide a curated selection of high-quality, niche products that appeal to vegan, vegetarian, and flexitarian diets. Furthermore, they serve as hubs for education and exploration, showcasing new protein sources and sustainable food options that promote environmental responsibility.
Europe region dominated the largest share of the market during the extrapolated period, due to rising awareness of health and sustainability concerns associated with animal farming, coupled with a growing number of consumers adopting vegetarian or flexitarian diets. Plant-based proteins offer a viable alternative to traditional animal-derived proteins, catering to diverse dietary preferences and lifestyles. Furthermore, innovations in food technology have led to the development of plant-based products that mimic the taste, texture, and nutritional profile of meat and dairy products, further accelerating regional growth.
Europe region is estimated to witness substantial growth over the projection period. Stringent regulations aimed at sustainability, health and animal welfare are compelling food manufacturers to innovate and diversify their product offerings across the region. Policies promoting plant-based diets, reducing meat consumption, and fostering sustainable agricultural practices are creating a conducive environment for the expansion of protein alternatives such as plant-based proteins, algae-based proteins and cultured meat throughout the region. As a result, Europe is emerging as a hub for protein alternatives, attracting investments and driving market growth while promoting a shift towards more sustainable and healthy food choices.
Key players in the market
Some of the key players in Protein Alternatives market include Archer Daniels Midland Company, Aspire Food Group, Axiom Foods Inc, Bluebiotech International GmbH, Burcon Nutrascience Corporation, Calysta, Inc, Cargill, Incorporated, Cellena Inc, Glanbia PLC, JR Unique Foods Ltd, Kerry Group Plc and Plantible Foods, Inc.
In February 2024, Roquette expanded its Nutralys plant protein line by launching four new pea protein products, encompassing isolates, hydrolysates, and textured variants. These versatile pea proteins are designed to address formulation challenges in plant-based foods and high-protein nutritional products. They pave the way for innovation in various items, including nutritional bars, protein beverages, and plant-based meat and dairy alternatives.
In May 2023, ADM and Air Protein established a Strategic Development Agreement (SDA) to jointly develop innovative protein sources for nutrition. Air Protein produces protein through air-based techniques that bypass traditional agriculture and farmland, mitigating supply chain risks. This collaboration combines ADM's expertise in nutrition, formulation, and research with Air Protein's pioneering landless agriculture platform to enhance cost-effective protein ingredients for North American meat substitutes.
In June 2022, AMCO Proteins (US) acquired a 40,000-square-foot facility in Mountain Top, Pennsylvania, which includes five food-grade production rooms and storage space for over 500 pallets. This new facility is anticipated to boost and expand the company's spray drying, blending, and milling operations, thereby enhancing its business capabilities in these areas.
In April 2022, ADM made a strategic investment of USD 300 million to enhance alternative protein production at its Decatur, Illinois plant, aiming to double the facility's soy extrusion capacity. This investment also includes the construction of a Protein Innovation Center, equipped with labs, test kitchens, and pilot-scale production facilities, to strengthen the company's R&D capabilities.